Omron Corp. (OTCMKTS:OMRNY - Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 165,095 shares traded hands during trading, an increase of 194% from the previous session's volume of 56,175 shares.The stock last traded at $29.23 and had previously closed at $28.51.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of Omron from a "strong sell" rating to a "hold" rating in a report on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold".
Get Our Latest Stock Analysis on OMRNY
Omron Price Performance
The company has a quick ratio of 1.37, a current ratio of 2.11 and a debt-to-equity ratio of 0.13. The firm's fifty day moving average price is $29.73 and its two-hundred day moving average price is $27.61. The stock has a market capitalization of $6.02 billion, a PE ratio of 36.92, a PEG ratio of 0.33 and a beta of 1.00.
Omron (OTCMKTS:OMRNY - Get Free Report) last announced its earnings results on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.36 by ($0.19). Omron had a net margin of 2.80% and a return on equity of 2.46%. The business had revenue of $1.41 billion for the quarter, compared to analysts' expectations of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. On average, equities analysts predict that Omron Corp. will post 0.42 earnings per share for the current year.
Institutional Trading of Omron
An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC raised its holdings in shares of Omron Corp. (OTCMKTS:OMRNY - Free Report) by 50.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,129 shares of the company's stock after buying an additional 716 shares during the period. GAMMA Investing LLC's holdings in Omron were worth $54,000 at the end of the most recent quarter. 1.09% of the stock is owned by institutional investors and hedge funds.
Omron Company Profile
(
Get Free Report)
Omron Corporation OTCMKTS: OMRNY is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.
While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.